Campath, calcineurin inhibitor reduction, and chronic allograft nephropathy (the 3C Study) – results of a randomized controlled clinical trial
Richard Haynes; Lisa Blackwell; Natalie Staplin; William G. Herrington; Jonathan Emberson; Parminder K. Judge; Benjamin C. Storey; Martin J. Landray; Paul N. Harden; Colin Baigent; Peter Friend
Author Information: MRC Population Health Research Unit Nuffield Department of Population Health University of Oxford
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.